Refocusing BASF Will Cut 350 Jobs in Plant Biotechnology R&D
BASF is refocusing its plant biotechnology research portfolio. The company will adjust the site footprint of its plant biotechnology research and development network in North America and Europe and intends to reduce approximately 350 positions. Currently approximately 700 employees work in plant biotechnology R&D.
Ludwigshafen/Germany – Research and field sites in Research Triangle Park and Ames, USA, Berlin and Limburgerhof, Germany, Ghent, Belgium, and Brazil will be kept but are planned to be reduced in size. The field testing sites in Kekaha on Hawaii as well as the sites in India and Puerto Rico will be closed. The restructuring is expected to be completed by the end of 2016. Of the 350 positions which should be deleted, 140 are in North America and 180 in Europe.
“We will discontinue projects with extremely high technical challenges, which would require significant time and financial investment,” said Dr. Harald Schwager, member of the Board of Executive Directors of BASF and responsible for Bioscience Research. The plant biotechnology research portfolio will focus on high potential projects in herbicide tolerance and fungal resistant soybean.
The project on polyunsaturated omega-3 fatty acids in canola seeds will also be continued. The yield and stress collaboration agreement regarding corn and soybean with Monsanto is not affected. Discovery and early development projects in yield and stress, including corn and soybean will be streamlined, rice yield as well as corn fungal resistance projects will be discontinued.